Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Track record Movers The Lead Compound

Home › Targets › OX40L

OX40L (1 companies · 2 programs)

Companies with an active program directed at OX40L.

Apogee Therapeutics, Inc. APGE

APG990 Phase 1
APG279 — Atopic Dermatitis Phase 1

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.